SearchTags: cancer researchAlimta Cisplatin Combination Confirmed to Improve Survival Rates in Mesothelioma Patients11th February 2007 People with mesothelioma â” a form of cancer associated with asbestos exposure â” have a higher survival rate when treated with a combination of two cancer drugs, a large multicenter study finds.
Mesothelioma, a rare but aggressive form of cancer that o… more » Categories: Asbestos Information Breakthrough Mesothelioma Diagnosis Procedure Receives FDA Approval25th January 2007 Fujirebio Diagnostics, Inc. (FDI) received approval from the Food & Drug Administration (FDA) under the Humanitarian Device Exemption (HDE) program for the MesoMark Assay, the world’s first in-vitro test for mesothelioma, a form of cancer link… more » Categories: Asbestos Information Alfacell Applies For Exclusive Patent to Produce and Develop Onconase17th December 2006 Alfacell Corporation (Nasdaq: ACEL), a biopharmaceutical company focused on the discovery, development and commercialization of novel ribonuclease therapeutics for cancer, today announced it has filed an application with the U.S. Food and Drug Administra… more » Categories: Asbestos Information Olive Leaf Report Endorses Holistic Treatments for Lung Cancer Symptoms in 9/11 Workers11th October 2006 In a Special Report published in the September/October issue of EXPLORE: The Journal of Science and Healing, Claire Haaga Altman, President and Dr. Kamau Kokayi, MD, Medical Director of the Olive Leaf Wholeness Center in New York City outlined the progra… more » Categories: Asbestos Information Standard Procedures for Mesothelioma Treatment08th October 2006 Treatment for mesothelioma depends on the location of the cancer, the stage of the disease, and the patient’s age and general health. Standard treatment options include surgery, radiation therapy, and chemotherapy. Sometimes, these treatments are c… more » Categories: Asbestos Information |
|
||||
